Read more about Intas Pharma files draft prospectus for IPO on Business Standard. Drug maker Intas Pharmaceuticals today said it has filed. Intas Pharmaceuticals, has filed its draft red herring prospectus (DRHP) with Securities and Exchange Board of India (SEBI) for an initial public. Intas Pharma DRHP News: Latest and Breaking News on Intas Pharma DRHP. Explore Intas Pharma DRHP profile at Times of India for photos, videos and latest .
|Published (Last):||4 August 2004|
|PDF File Size:||4.41 Mb|
|ePub File Size:||3.3 Mb|
|Price:||Free* [*Free Regsitration Required]|
The Ahmedabad-based company is considering licensing agreements with hospital-based businesses in these markets. Intas Pharma is a vertically integrated Indian pharmaceutical company with global operations, engaged in the development, manufacture and dthp of pharmaceutical formulation. Drug-maker Intas Pharmaceuticals has merged all its group intaw and subsidiaries over concerns about low profits.
Binish Hasmukh Chudgar, Mr. Desi pharma companies top in biosimilars globally. The IPO will be made through a public issue of equity shares of face value of Rs.
Intas Pharmaceuticals files DRHP for IPO
Its products are marketed in over 60 countries, either directly, through its subsidiaries or indirectly, through supply, distribution and other arrangements with various leading global pharmaceutical companies. Subscribe to BioSpectrum India. It is currently ranked as the 12th largest pharmaceutical company in the country with a 2. Chandra kicks off divestment plan. In what could further strengthen its business in European and non-European countries, Ahmedabad based Intas Pharmaceuticals Ltd has acquired hospital business of Combino Pharm in Spain and Portugal for an undisclosed sum.
All rights reserved Disclaimer. Monday, 31 December Mon, Dec 31, Updated Please fill the all fields. Nimish Hasmukhbhai Chudgar, Dr. Please click here to Sign-in or Sign-up. Visit Our Digital Magazine: It has also extended its presence into other therapy areas such as gynecology, infertility, arthritis and the respiratory. Medical Council of India MCI will investigate a complaint against 11 doctors from Madhya Pradesh who are charged with accepting foreign jaunts sponsored by pharmaceutical company.
According to sources, the company has begun the groundwork for the IPO and approached merchant bankers a couple of months ago. Intas Pharma merges group companies, subsidiaries. Intas Pharma eyes hospitals in Europe, US.
MCI to probe foreign jaunts by MP doctors. Rahul Gandhi listed as ‘non-Hindu’.
Sources said the group has started a process to sell drug discovery services company Advinus Therapeutics, drawing interest from private equity funds Kedaara Capital and True North as well as from strategic players, GVK Biosciences and Lambda, a unit of Intas Pharma. Please note that comments are moderated and are generally published if they are on-topic and not abusive.
The promoters of the company are Mr. Intas to buy Teva’s UK, Ireland assets for mn pounds.
Email Enter a valid email address. Sun Pharma in early talks to buy Intas Pharma. Web Interface Conceived and Powered By: Intas Pharma launches first etanercept biosimilar. rdhp
Intas Pharmaceuticals files DRHP for IPO –
From around the Web. ChrysCap backs Curatio in latest pharma bet. We will get in touch with you shortly.